直近一年間の累計
アクセス数 : ?
ダウンロード数 : ?
ID 116090
著者
板東, 浩 Tokushima University|Integrative Medicine Japan KAKEN研究者をさがす
キーワード
Hyperuricemia
Urate-Lowering Therapy
Selective Urate Reabsorption Inhibitor
Chronic Kidney Disease
Preventing Early Renal Loss in Diabetes
American College of Rheumatology
資料タイプ
学術雑誌論文
抄録
Hyperuricemia is a clinical important problem and its prevalence has been increased. Latest topics are described. The guideline adequately managing gout was published from American College of Rheumatology (ACR). Various optimal uses of urate-lowering therapy (ULT) were presented. The cardiorenal effects of hyperuricemia have been investigated for years. Regarding the patients on chronic kidney disease (CKD) and high risk of progression, ULT with allopurinol did not show the decline in eGFR compared to the control. Recently, dotinurad that is a new selective urate reabsorption inhibitor (SURI) would be applied to medical practice. Low-dose dotinurad showed satisfactory pharmacological efficacy.
掲載誌名
Diabetes Research : Open Access
出版者
Asploro
3
1
開始ページ
16
終了ページ
19
発行日
2021-04-27
権利情報
This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
出版社版DOI
出版社版URL
フルテキストファイル
言語
eng
著者版フラグ
出版社版
部局
医学系